IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK – IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will use IFF’s Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland.
"Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect."
IFF’s DEB platform leverages biotechnology by using plant-based sugars and enzymes under mild process conditions to create biobased materials, which can be tailored for specific product applications. This allows manufacturers to replace traditional fossil-based synthetic polymers with more sustainable alternatives. This highly efficient enzymatic polymerization process converts plant sugars to biopolymers, offering superior purity and consistency compared to conventional synthetic polymers. These tailored biopolymers enhance product performance across diverse applications.
“Since 2020, we’ve been collaborating with IFF using the DEB platform technology, which has allowed us to bring sustainable innovation to our key markets,” said Antti Salminen, CEO, Kemira Oyj. “The new joint venture will build on this initial success, enabling us to scale up production and provide new performance-competitive alternatives to fossil-based products in key markets, including paper and board packaging, paper coatings, and water treatment, while continuing to develop opportunities across other growth markets.”
Operating as an independent entity in Kotka, Finland, the joint venture will manufacture a specific line of products enabled by DEB technology for exclusive use by IFF and Kemira. The creation of Alpha Bio is expected to generate approximately 30 direct new jobs in the Kotka area with additional job creation during the project’s construction phase.
Categories
Countries
Companies
Latest news
MSSA doubles production capacity for sodium methylate in La Rochelle, France
The strategic investment will double MSSA's annual production capacity for sodium methylate from 20,000 tonnes to 40,000 tonnes, reinforcing the company's commitment to meeting the growing demand f...
Dreexo Energy to Launch Circular Economy Plant in Cádiz, Advancing Sustainable Industry in Andalucía
Construction of a new facility in the Cádiz Free Trade Zone. The project is expected to break ground in early 2026 and be operational by year’s end.
BASF invests in new semiconductor-grade sulfuric acid plant in Ludwigshafen, Germany
BASF SE, Ludwigshafen →Essential ultra-pure chemical enabling advanced semiconductor manufacturing processes New capacity meets growing demand for the manufacturing of chips in Europe
Vioneo appoints Wood to design world’s first industrial scale fossil-free plastics facility in Antwerp, Belgium
Port Of Antwerp →the renewably powered and energy efficient plant will be the first facility in the world capable of achieving the production of fossil-free plastics using green methanol at an industrial scale.